Stephen M. Stahl
Department of Psychiatry
University of California San Diego
San Diego
CA, USA and Department of Psychiatry
UK E-mail:
Name/email consistency: high
- Structural imaging of schizophrenia: is the modern psychiatrist becoming a 'disease scene investigator?': An editorial comment to Perlini C, Bellani M, Brambilla P. 'Structural imaging techniques in schizophrenia' (1). Stahl, S.M. Acta. Psychiatr. Scand (2012)
- A post hoc analysis of negative symptoms and psychosocial function in patients with schizophrenia: a 40-week randomized, double-blind study of ziprasidone versus haloperidol followed by a 3-year double-blind extension trial. Stahl, S.M., Malla, A., Newcomer, J.W., Potkin, S.G., Weiden, P.J., Harvey, P.D., Loebel, A., Watsky, E., Siu, C.O., Romano, S. J. Clin. Psychopharmacol (2010)
- Agomelatine in the treatment of major depressive disorder: an 8-week, multicenter, randomized, placebo-controlled trial. Stahl, S.M., Fava, M., Trivedi, M.H., Caputo, A., Shah, A., Post, A. J. Clin. Psychiatry (2010)
- Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies. Stahl, S., Lombardo, I., Loebel, A., Mandel, F.S. J. Affect. Disord (2010)
- Fibromyalgia--pathways and neurotransmitters. Stahl, S.M. Hum. Psychopharmacol (2009)
- Which comes first: atypical antipsychotic treatment or cardiometabolic risk? Stahl, S.M., Mignon, L., Meyer, J.M. Acta. Psychiatr. Scand (2009)
- Why psychiatrists should not ignore pain in their patients--focus on fibromyalgia?. Stahl, S.M., Briley, M. Hum. Psychopharmacol (2009)
- Analysis of the rate of improvement of specific psychic and somatic symptoms of general anxiety disorder during long-term treatment with venlafaxine ER. Stahl, S.M., Ahmed, S., Haudiquet, V. CNS. Spectr (2007)
- Negative symptoms of schizophrenia: a problem that will not go away. Stahl, S.M., Buckley, P.F. Acta. Psychiatr. Scand (2007)
- Novel mechanism of antidepressant action: norepinephrine and dopamine disinhibition (NDDI) plus melatonergic agonism. Stahl, S.M. Int. J. Neuropsychopharmacol. (2007)
- High-cost use of second-generation antipsychotics under California's Medicaid program. Stahl, S.M., Grady, M.M. Psychiatr. Serv (2006)
- Finding what you are not looking for: strategies for developing novel treatments in psychiatry. Stahl, S.M. NeuroRx (2006)
- A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Stahl, S.M., Grady, M.M. Curr. Med. Chem. (2004)
- Focus on antipsychotic polypharmacy: evidence-based prescribing or prescribing-based evidence?. Stahl, S.M. Int. J. Neuropsychopharmacol. (2004)
- Examination of nighttime sleep-related problems during double-blind, placebo-controlled trials of galantamine in patients with Alzheimer's disease. Stahl, S.M., Markowitz, J.S., Papadopoulos, G., Sadik, K. Curr. Med. Res. Opin (2004)
- Understanding pain in depression. Stahl, S., Briley, M. Hum. Psychopharmacol (2004)
- Differences in mechanism of action between current and future antidepressants. Stahl, S.M., Grady, M.M. J. Clin. Psychiatry (2003)
- Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial. Stahl, S.M., Gergel, I., Li, D. J. Clin. Psychiatry (2003)
- The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice. Stahl, S.M., Shayegan, D.K. J. Clin. Psychiatry (2003)
